| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $490.7M | +110.5% |
| Cost of Revenue | $10.3M | +33.5% |
| R&D Expense | $206.0M | -5.3% |
| SG&A Expense | $337.2M | +27.7% |
| Operating Income | -$62.8M | +80.6% |
| Pre-tax Income | -$49.3M | +84.6% |
| Income Tax | $988K | +723.3% |
| Net Income | -$25.5M | +92.1% |
| EPS (Basic) | -$0.29 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $93.0M | +58.9% |
| Accounts Receivable | $80.1M | +195.5% |
| Inventory | $36.2M | +483.1% |
| Current Assets | $437.6M | +5.0% |
| Total Assets | $605.2M | +1.9% |
| Current Liabilities | $159.9M | -20.3% |
| Total Liabilities | $490.4M | -8.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $37.8M | +115.9% |
| Investing Cash Flow | $27.9M | -71.9% |
| Financing Cash Flow | -$33.5M | -124.0% |
| +92.9% |
| EPS (Diluted) | -$0.29 | +92.9% |
| Stockholders' Equity |
| $114.8M |
| +94.4% |